Perifosine + Sunitinib Malate for Patients With Advanced Cancers

This study has been terminated.

( AOI Pharma is reassessing the development strategy for perifosine. )

Study NCT00399152 Information provided by Keryx / AOI Pharmaceuticals, Inc.

First Received: November 9, 2006 Last Updated: February 17, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	May 2009
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)